GE HealthCare forecasts annual profit above Wall Street estimates due to strong demand for diagnostic and imaging devices. Revenue from imaging unit rose 6.6% to $2.55 billion in Q4, boosting shares by 2.4%. CEO cites capital investment trends and demand for new products as key drivers. Company expects lower tariff impact in 2026 compared to 2025. Adjusted profit per share for 2026 expected to be $4.95 to $5.15, exceeding analyst estimates of $4.92. Organic revenue growth forecasted at 3% to 4% for 2026. In Q4, company earned $1.44 per share, surpassing estimates of $1.40, with total sales reaching $5.7 billion, higher than analysts’ expectations.

Read more at Yahoo Finance: GE HealthCare forecasts 2026 profit above estimates on strong demand for medical devices